The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation
Open accessAbstract
Histone acetylation plays important roles in gene regulation, DNA replication, and the response to DNA damage, and it is frequently deregulated in tumors. We postulated that tumor cell histone acetylation levels are determined in part by changes in acetyl coenzyme A (acetyl-CoA) availability mediated by oncogenic metabolic reprogramming. Here, we demonstrate that acetyl-CoA is dynamically regulated by glucose availability in cancer cells and that the ratio of acetyl-CoA:coenzyme A within the nucleus modulates global histone acetylation levels. In vivo, expression of oncogenic Kras or Akt stimulates histone acetylation changes that precede tumor development. Furthermore, we show that Akt's effects on histone acetylation are mediated through the metabolic enzyme ATP-citrate lyase and that pAkt(Ser473) levels correlate significantly with histone acetylation marks in human gliomas and prostate tumors. The data implicate acetyl-CoA metabolism as a key determinant of histone acetylation levels in cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, citrate export to the cytosol and subsequent cleavage by ACL provides a major source of cytosolic acetyl-CoA that is the obligate substrate for both de novo lipid synthesis and protein acetylation reactions (39, 187, 188).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [188]
In the citing paper
“Accordingly, oncogenic activation of the PI3K–AKT signaling axis increases acetyl-CoA levels and promotes elevated histone acetylation both in vitro and in tumors (188).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [188]
In the citing paper
“Immunohistochemical analysis of glioblastoma and prostate tumor samples has shown that Akt activation levels closely correlate with global histone acetylation status (Lee et al., 2014).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Lee et al., 2014
In the citing paper
“Furthermore, studies have shown that both the glucose- and oncogene-driven increases in global histone acetylation are blocked by ACLY inhibition (Lee et al., 2014; Wellen et al., 2009).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Lee et al., 2014
In the citing paper
“Indeed, withdrawal and readdition of glucose, as well as activation of oncogenic signaling via introduction of an oncogenic KRAS mutant or a constitutively active form of Akt, increase total histone acetylation, which, in turn, promotes the enhanced and broader gene expression (Lee et al., 2014).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Lee et al., 2014
In the citing paper
“The effect of itaconate on ROS production is consistent with a previous study in zebrafish macrophages, which demonstrated that IRG1 was essential for OXPHOS-driven mtROS production and bactericidal killing172.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
ATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298
Self-citationEMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., et al. (2012) · Nature · doi:10.1038/nature10860 · Cited by 1,985
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 562
Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential
Wagner, A., Kosnacova, H., Chovanec, M., & Jurkovičová, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147897 · Cited by 54
Probing coenzyme A homeostasis with semisynthetic biosensors
Xue, L., Schnacke, P., Frei, M. S., Koch, B., Hiblot, J., Wombacher, R., Fabritz, S., & Johnsson, K. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01172-7 · Cited by 53
Wartewig, T., Daniels, J., Schulz, M., Hameister, E., Joshi, A., Park, J., Morrish, E., Venkatasubramani, A. V., Cernilogar, F. M., van Heijster, F. H. A., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00635-7 · Cited by 54
ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses
Kaymak, I., Watson, M. J., Oswald, B. M., Ma, S., Johnson, B. K., DeCamp, L. M., Mabvakure, B. M., Luda, K. M., Ma, E. H., Lau, K. H., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231820 · Cited by 53
Developmental origins and oncogenic pathways in malignant brain tumors
Lu, Q. R., Qian, L., & Zhou, X. (2019) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.342 · Cited by 55
H3 ubiquitination by NEDD4 regulates H3 acetylation and tumorigenesis
Zhang, X., Li, B., Rezaeian, A. H., Xu, X., Chou, P., Jin, G., Han, F., Pan, B.-S., Wang, C., Long, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14799 · Cited by 54
Acetyl-CoA and Metabolite Fluxes Regulate White Adipose Tissue Expansion
Felix, J. B., Cox, A. R., & Hartig, S. M. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.02.008 · Cited by 52
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
Pardo, J. C. T., de Porras, V. R., Gil, J., Pous, A. F., Puig‐Domingo, M., & Jordà, M. (2022) · Nutrients · doi:10.3390/nu14040851 · Cited by 55
Nutrient Exploitation within the Tumor–Stroma Metabolic Crosstalk
Morandi, A., Giannoni, E., & Chiarugi, P. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.11.001 · Cited by 50
Taylor, H. E., Calantone, N., Lichon, D., Hudson, H., Clerc, I., Campbell, E. M., & D’Aquila, R. T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107810 · Cited by 48
Osinalde, N., Mitxelena, J., Sánchez-Quiles, V., Akimov, V., Aloria, K., Arizmendi, J. M., Zubiaga, A. M., Blagoev, B., & Kratchmarova, I. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.057158 · Cited by 48
Lin, T., Yang, W., Luo, W., Zhang, L., Mai, Y., Li, Z., Liu, S., Jiang, L.-J., Liu, P., & Li, Z. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1198607 · Cited by 50
Global Profiling of Acetyltransferase Feedback Regulation
Montgomery, D. C., Garlick, J. M., Kulkarni, R. A., Kennedy, S., Allali‐Hassani, A., Kuo, Y., Andrews, A. J., Wu, H., Vedadi, M., & Meier, J. L. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b03036 · Cited by 48
LKB1 and cancer: The dual role of metabolic regulation
Li, T., & Zhu, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110872 · Cited by 47
Targeting Dysregulated Lipid Metabolism in Cancer with Pharmacological Inhibitors
Gupta, A., Das, D., & Taneja, R. (2024) · Cancers · doi:10.3390/cancers16071313 · Cited by 52
Chen, Y., Qian, J., He, Q., Zhao, H., Toral‐Barza, L., Shi, C., Zhang, X., Wu, J., & Yu, K. (2016) · Oncotarget · doi:10.18632/oncotarget.8279 · Cited by 50
Dai, M., Yang, B., Chen, J., Liu, F., Zhou, Y., Zhou, Y., Xu, Q., Jiang, S., Zhao, S., Li, X., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.024 · Cited by 49
Cancer cell metabolism connects epigenetic modifications to transcriptional regulation
Morrison, A. J. (2021) · FEBS Journal · doi:10.1111/febs.16032 · Cited by 47
Iqbal, M. A., Siddiqui, S. I., Rehman, A. U., Siddiqui, F. A., Singh, P. K., Kumar, B., & Saluja, D. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12894 · Cited by 46
Jiang, Y., Hu, T., Wang, T., Shi, X. E., Kitano, A., Eagle, K., Hoegenauer, K. A., Konopleva, M. Y., Lin, C. Y., Young, N. L., et al. (2019) · Blood · doi:10.1182/blood.2019001076 · Cited by 47
Chai, S., Xu, X., Wang, Y., Zhou, Y., Zhang, C., Yang, Y., Yang, Y., Xu, H., Xu, R., & Wang, K. (2015) · Oncotarget · doi:10.18632/oncotarget.3866 · Cited by 45
Metabolic Signaling to Epigenetic Alterations in Cancer
Kim, J., & Yeom, Y. I. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.185 · Cited by 45
Metabolism and Transcription in Cancer: Merging Two Classic Tales
Martín-Martín, N., Carracedo, A., & Torrano, V. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00119 · Cited by 43
Molusky, M. M., Hsieh, J., Lee, S. X., Ramakrishnan, R., Tascau, L., Haeusler, R. A., Accili, D., & Tall, A. R. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311212 · Cited by 45
Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase
Namgaladze, D., Zukunft, S., Schnütgen, F., Kurrle, N., Fleming, I., Fuhrmann, D. C., & Brüne, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02858 · Cited by 44
Regulation of Metabolic Homeostasis in Cell Culture Bioprocesses
O’Brien, C. M., Mulukutla, B. C., Mashek, D. G., & Hu, W. (2020) · Trends in biotechnology · doi:10.1016/j.tibtech.2020.02.005 · Cited by 43
Le-tian, Z., Cheng-zhang, H., Zhang, X., Zhang, Q., Yan, Z., Wei, Q., Sheng-xuan, W., Xu, Z., Li, R., Ting-jun, L., et al. (2020) · BMC Genomics · doi:10.1186/s12864-020-06837-y · Cited by 43
Cell surface GRP78 signaling: An emerging role as a transcriptional modulator in cancer
Gopal, U., & Pizzo, S. V. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30030 · Cited by 44
Min, Z., Long, X., Zhao, H., Zhen, X., Li, R., Li, M., Fan, Y., Yu, Y., Zhao, Y., & Qiao, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.567028 · Cited by 46
Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer
Senapati, P., Kato, H., Lee, M., Leung, A., Thai, C., Sanchez, A., Gallagher, E. J., LeRoith, D., Seewaldt, V. L., Ann, D. K., et al. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0290-9 · Cited by 43
ZFP36-mediated mRNA decay regulates metabolism
Cicchetto, A. C., Jacobson, E. C., Sunshine, H., Wilde, B. R., Krall, A. S., Jarrett, K. E., Sedgeman, L. R., Turner, M., Plath, K., Iruela‐Arispe, M. L., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112411 · Cited by 42
Unraveling the intricate relationship between lipid metabolism and oncogenic signaling pathways
Khan, F., Elsori, D. H., Verma, M., Pandey, S., Rab, S. O., Siddiqui, S., Alabdallah, N. M., Saeed, M., & Pandey, P. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1399065 · Cited by 45
Lazaropoulos, M. P., Gibb, A., Chapski, D. J., Nair, A. A., Reiter, A. N., Roy, R., Eaton, D., Bedi, K. C., Margulies, K. B., Wellen, K. E., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00502-3 · Cited by 44
Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy
Han, B., Lin, X., & Hu, H. (2024) · Translational Breast Cancer Research · doi:10.21037/tbcr-24-29 · Cited by 44
ANGPTL3: a novel biomarker and promising therapeutic target
Jiang, S., Qiu, G.-H., Zhu, N., Hu, Z., Liao, D., & Li, Q. (2019) · Journal of drug targeting · doi:10.1080/1061186x.2019.1566342 · Cited by 41
Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
Wang, J., Ye, W., Yan, X., Guo, Q., Ma, Q., Lin, F., Huang, J., & Jin, J. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1884-5 · Cited by 43
Protein Kinase B (PKB/AKT) Protects IDH-Mutated Glioma from Ferroptosis via Nrf2
Liu, Y., Chou, F.-J., Lang, F., Zhang, M., Song, H., Zhang, W., Davis, D. L., Briceno, N., Zhang, Y., Cimino, P. J., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3179 · Cited by 43
Colorectal Cancer: Pathogenesis and Targeted Therapy
Li, J., Pan, J., Wang, L., Ji, G., & Dang, Y. (2025) · MedComm · doi:10.1002/mco2.70127 · Cited by 48
Féron, O. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.140 · Cited by 39
Nuclear Functions of TOR: Impact on Transcription and the Epigenome
Laribee, R. N., & Weisman, R. (2020) · Genes · doi:10.3390/genes11060641 · Cited by 43
Lipid Synthesis Is a Metabolic Liability of Non–Small Cell Lung CancerPreprint
Svensson, R. U., & Shaw, R. J. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030874 · Cited by 40
Acetyl-CoA biosynthesis drives resistance to histone acetyltransferase inhibition
Bishop, T. R., Subramanian, C., Bilotta, E. M., Garnar-Wortzel, L., Ramos, A. R., Zhang, Y., Asiaban, J. N., Ott, C. J., Rock, C. O., & Erb, M. A. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01320-7 · Cited by 43
Cytosolic acetyl-coenzyme A is a signalling metabolite to control mitophagy
Zhang, Y., Shen, X. L., Shen, Y., Wang, C., Yu, C., Han, J., Cao, S., Qian, L., Ma, M., Huang, S., et al. (2025) · Nature · doi:10.1038/s41586-025-09745-x · Cited by 48
Zhang, R., Li, H., Zhang, S., Zhang, Y., Wang, N., Zhou, H., He, H., Hu, G., Zhang, T., & Ma, W. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0610-1 · Cited by 41
Wu, S., Chen, W., Jing, Z.-T., Liu, W., Lin, X., & Lin, X. (2018) · Journal of Virology · doi:10.1128/jvi.01273-18 · Cited by 39
mTOR complex 2 is an integrator of cancer metabolism and epigenetics
Masui, K., Harachi, M., Cavenee, W. K., Mischel, P. S., & Shibata, N. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.03.001 · Cited by 39
Grobs, Y., Romanet, C., Lemay, S.-E. S., Bourgeois, A., Voisine, P., Théberge, C., Sauvaget, M., Breuils‐Bonnet, S., Martineau, S., Kabbout, R. E., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.ado7824 · Cited by 42
Dhall, A., Zee, B. M., Yan, F., & Blanco, M. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00432 · Cited by 38
Acetylation-mediated remodeling of the nucleolus regulates cellular acetyl-CoA responses
Houston, R., Sekine, S., Calderon, M. J., Seifuddin, F., Wang, G., Kawagishi, H., Malide, D. A., Li, Y., Guček, M., Pirooznia, M., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000981 · Cited by 37
Genomic and transcriptomic landscape of conjunctival melanoma
Cisarova, K. V., Folcher, M., Zaoui, I. E., Gobert, R. P., Peter, V. G., Royer‐Bertrand, B., Zografos, L., Schalenbourg, A., Nicolas, M., Rimoldi, D., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009201 · Cited by 39
Amino Acid Transporters on the Guard of Cell Genome and Epigenome
Kahya, U., Köseer, A. S., & Dubrovska, A. (2021) · Cancers · doi:10.3390/cancers13010125 · Cited by 37
Guha, M., Srinivasan, S., Guja, K. E., Mejía, E., García–Díaz, M., Johnson, F. B., Ruthel, G. T., Kaufman, B. A., Rappaport, E. F., Glineburg, M. R., et al. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.45 · Cited by 38
mTORC2 links growth factor signaling with epigenetic regulation of iron metabolism in glioblastoma
Masui, K., Harachi, M., Ikegami, S., Yang, H., Onizuka, H., Yong, W. H., Cloughesy, T. F., Muragaki, Y., Kawamata, T., Arai, N., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011519 · Cited by 38
Wu, D., Yan, Y., Wei, T., Ye, Z., Xiao, Y., Pan, Y., Orme, J. J., Wang, D., Wang, L., Ren, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108744 · Cited by 37
iGlu_AdaBoost: Identification of Lysine Glutarylation Using the AdaBoost Classifier
Dou, L., Li, X., Zhang, L., Xiang, H., & Xu, L. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00314 · Cited by 36
Extracellular Citrate Is a Trojan Horse for Cancer Cells
Petillo, A., Abruzzese, V. D., Koshal, P., Ostuni, A., & Bisaccia, F. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.593866 · Cited by 36
Janczar, S., Janczar, K., Pastorczak, A. K., Harb, H., Paige, A. J. W., Zalewska‐Szewczyk, B., Danilewicz, M., & Mlynarski, W. M. (2017) · Cancers · doi:10.3390/cancers9010002 · Cited by 36
Wang, S., Chen, Y., Chow, J., Chien, M., Yang, S., Wen, Y., Lee, W.-J., & Tseng, T. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22807 · Cited by 38
Vadla, R., & Haldar, D. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1404207 · Cited by 34
De Novo Lipogenesis as a Source of Second Messengers in Adipocytes
Hsiao, W., & Guertin, D. A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1264-9 · Cited by 36
Insights About Circadian Clock and Molecular Pathogenesis in Gliomas
Arafa, K., & Emara, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00199 · Cited by 34
Yang, D., Peng, M., Hou, Y., Qin, Y., Wan, X., Zhu, P., Liu, S., Yang, L., Zeng, H., Jin, T., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2714-7 · Cited by 36
Erasing gametes to write blastocysts: metabolism as the new player in epigenetic reprogramming
Milazzotto, M. P., de Lima, C. B., da Fonseca, A. M., dos Santos, É. C., & Ispada, J. (2020) · Animal Reproduction · doi:10.1590/1984-3143-ar2020-0015 · Cited by 34
Chemical Catalysis Intervening to Histone Epigenetics
Nozaki, T., & Kanai, M. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00144 · Cited by 34
Targeting dysregulated lipid metabolism in the tumor microenvironment
Kim, D., Song, N., & Yim, H. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01473-y · Cited by 38
Integration of transcriptional and metabolic control in macrophage activation
Natoli, G., Pileri, F., Gualdrini, F., & Ghisletti, S. (2021) · EMBO Reports · doi:10.15252/embr.202153251 · Cited by 33
Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression
Fukano, M., Park, M., & Deblois, G. (2021) · Cancers · doi:10.3390/cancers13184699 · Cited by 36
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 38
Niu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 34
Li, A. M., & Ye, J. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-120857 · Cited by 31
Protein post-translational modifications and tumor immunity: A pan-cancer perspective
Zhang, H., Yan, Q., Jiang, S., Hu, D., Lu, P., Li, S., Sandai, D. A., Zhang, H., Zhang, W., & Zhu, C. (2025) · Physics of Life Reviews · doi:10.1016/j.plrev.2025.10.001 · Cited by 36
Metabolic modulation of cancer: a new frontier with great translational potential
Kinnaird, A. S., & Michelakis, E. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1250-2 · Cited by 32
G9a inhibition induced PKM2 regulates autophagic responses
Ahmad, F., Dixit, D., Joshi, S. D., & Sen, E. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.009 · Cited by 32
Prostate Cancer Energetics and Biosynthesis
Lin, C., Salzillo, T. C., Bader, D. A., Wilkenfeld, S. R., Awad, D., Pulliam, T. L., Dutta, P., Pudakalakatti, S., Titus, M. A., McGuire, S. E., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_10 · Cited by 33
Mallick, R., Bhowmik, P., & Duttaroy, A. K. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115591 · Cited by 35
Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma
Wang, H., Yi, X., Wang, X., Yang, Y., Zhang, H., Wang, H., Chen, J., Zhang, B., Guo, S., Wu, L., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115015 · Cited by 31
From the (Epi)Genome to Metabolism and Vice Versa; Examples from Hematologic Malignancy
Karagianni, P., Giannouli, S., & Voulgarelis, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126321 · Cited by 35
Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis
Kumar, N., & Mandal, C. C. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.724149 · Cited by 32
mTORC2 and Metabolic Reprogramming in GBM: at the Interface of Genetics and Environment
Masui, K., Cavenee, W. K., & Mischel, P. S. (2015) · Brain Pathology · doi:10.1111/bpa.12307 · Cited by 31
Chen, L., Miao, Y., Liu, M., Zeng, Y., Gao, Z., Peng, D., Hu, B., Xu, L., Zheng, Y., Xue, Y., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00254 · Cited by 29
Catalysis by protein acetyltransferase Gcn5
Albaugh, B. N., & Denu, J. M. (2020) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2020.194627 · Cited by 33
Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship
Pandkar, M. R., Dhamdhere, S. G., & Shukla, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188553 · Cited by 33
Novel therapeutic approaches to target neurodegeneration
de la Fuente, A. G., Pelucchi, S., Mertens, J., Luca, M. D., Mauceri, D., & Marcello, E. E. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16078 · Cited by 32
Stable Isotopes and LC–MS for Monitoring Metabolic Disturbances in Friedreich’s Ataxia Platelets
Worth, A. J., Basu, S. S., Deutsch, E. C., Hwang, W., Snyder, N. W., Lynch, D. R., & Blair, I. A. (2015) · Bioanalysis · doi:10.4155/bio.15.118 · Cited by 30
Effect of heterochromatin stability on intestinal stem cell aging in Drosophila
Jeon, H.-J., Kim, Y.-S., Kim, J., Heo, K., Pyo, J.-H., Yamaguchi, M., Park, J., & Yoo, M. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.04.001 · Cited by 31
Etoh, K., Araki, H., Koga, T., Hino, Y., Kuribayashi, K., Hino, S., & Nakao, M. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114496 · Cited by 31
Crosstalk between cellular metabolism and histone acetylation
Trefely, S., Doan, M. T., & Snyder, N. W. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.07.013 · Cited by 29
Pourshafie, N., Masati, E., Bunker, E. N., Nickolls, A. R., Thepmankorn, P., Johnson, K. R., Feng, X., Ekins, T. G., Grunseich, C., & Fischbeck, K. H. (2020) · JCI Insight · doi:10.1172/jci.insight.136539 · Cited by 30
Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism
Zhang, L., Yao, W., Xia, J., Wang, T., & Huang, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081885 · Cited by 30
A rapid method for quantifying free and bound acetate based on alkylation and GC-MS analysis
Tumanov, S., Bulusu, V., Gottlieb, E., & Kamphorst, J. J. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0157-5 · Cited by 29
Regulation of proteostasis and innate immunity via mitochondria-nuclear communication
Kim, S., Ramalho, T. R. D. O., & Haynes, C. M. (2024) · The Journal of Cell Biology · doi:10.1083/jcb.202310005 · Cited by 30
Oh, M. S., Abascal, J. W., Rennels, A. K., Salehi‐Rad, R., Dubinett, S. M., & Liu, B. (2025) · Cancers · doi:10.3390/cancers17061027 · Cited by 33
Associations among Metabolism, Circadian Rhythm and Age-Associated Diseases
Cao, Y., & Wang, R.-H. (2017) · Aging and Disease · doi:10.14336/ad.2016.1101 · Cited by 28
Karagiota, A., Kanoura, A., Paraskeva, E., Simos, G., & Chachami, G. (2022) · FEBS Journal · doi:10.1111/febs.16694 · Cited by 30
ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis
Bazilevsky, G. A., Affronti, H. C., Wei, X., Campbell, S. L., Wellen, K. E., & Marmorstein, R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006685 · Cited by 28
Lymphatic and blood systems: Identical or fraternal twins?
Morfoisse, F., & Noël, A. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105562 · Cited by 27
Regulatory effects of statins on Akt signaling for prevention of cancers
Hosseini, F. S., Ahmadi, A., Kesharwani, P., Hosseini, H., & Sahebkar, A. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111213 · Cited by 28
Lameirinhas, A., Miranda‐Gonçalves, V., Henrique, R., & Jerónimo, C. (2019) · Genes · doi:10.3390/genes10040264 · Cited by 28
Khan, A., Siddiqui, S. I., Husain, S. A., Mazurek, S., & Iqbal, M. A. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c01173 · Cited by 29
Ren, J., Ren, B., Liu, X., Cui, M., Fang, Y., Wang, X., Zhou, F., Gu, M., Xiao, R., Bai, J., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216649 · Cited by 30
Metadata
- Authors
- Lee, J. V., Carrer, A., Shah, S., Snyder, N. W., Wei, S., Venneti, S., Worth, A. J., Yuan, Z.-F., Lim, H.-W., Liu, S., Jackson, E., Aiello, N. M., Haas, N. B., Rebbeck, T. R., Judkins, A., Won, K.-J., Chodosh, L. A., Garcia, B. A., Stanger, B. Z., Feldman, M. D., Blair, I. A., & Wellen, K. E.
- Affiliations
- Abramson Cancer Center (US)
- University of Pennsylvania (US)
- Memorial Sloan Kettering Cancer Center (US)
- University of Southern California (US)
- Corresponding author
- Wellen, Kathryn E.
- ORCID
- Lee, Joyce V.
- Carrer, Alessandro
- Snyder, Nathaniel W.
- Wei, Shuanzeng
- Venneti, Sriram
- Yuan, Zuo-Fei
- Lim, Hee-Woong
- Liu, Shichong
- Aiello, Nicole M.
- Haas, Naomi B.
- Rebbeck, Timothy R.
- Judkins, Alexander
- Won, Kyoung-Jae
- Chodosh, Lewis A.
- Garcia, Benjamin A.
- Stanger, Ben Z.
- Feldman, Michael D.
- Blair, Ian A.
- Wellen, Kathryn E.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 20
- Issue
- 2
- Pages
- 306-319
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4151270
- OpenAlex
- W2022222857
- Cited by
- 563
- References
- 56
- Citations by year
- 2026: 23 · 2025: 40 · 2024: 51 · 2023: 56 · 2022: 48 · 2021: 68 · 2020: 62 · 2019: 54 · 2018: 41 · 2017: 38 · 2016: 39 · 2015: 30 · 2014: 10
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Padua Research Archive (University of Padova) (submittedVersion, other-oa)
- Funders
- Pew Charitable Trusts
- National Institutes of Health (DP2OD007447)
- National Cancer Institute (R01CA174761, K08CA181475, P30CA016520)
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK098769, P30 DK 19525, P30DK019525)
- National Institute of Environmental Health Sciences (P30ES0138328, T32ES019851, P30ES013508)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- histone acetylation, acetyl-CoA, metabolic reprogramming, Akt signaling, KRAS, ATP citrate lyase, glucose availability, coenzyme A, glioma, prostate cancer, cancer metabolism, epigenetic regulation
- MeSH terms
- Acetyl Coenzyme A, Acetylation, Brain Neoplasms, Coenzyme A, Glioma, Glucose, Histones, Humans, Interleukin-3, Male, Phosphorylation, Prostatic Neoplasms, Cluster Analysis, ras Proteins, Cell Line, Tumor, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
